Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)

Dr. Ahmed Kelani participates in the 29th Conference of the Arab Union of Manufacturers of Pharmaceuticals and Medical Appliances in Amman – Jordan.

July 1, 2026

Dr. Ahmed Kelani, Chairman of the Board and Managing Director:

"We are ready immediately for cooperation with pharmaceutical manufacturers in the Arab world to manufacture Biosimilars & Biologicals at our EIPICO 3 factory."

"The Arab Company for Active Pharmaceutical Ingredients (Arab API) will contribute to supporting pharmaceutical security in Egypt, and is capable of being the pillar of Arab pharmaceutical security."

These remarks were made during his participation in the 29th Conference of the Arab Union of Manufacturers of Pharmaceuticals and Medical Appliances, held under the theme "Modern Trends in Pharmaceutical Industries," which commenced on July 1, 2026, in Amman, Jordan.

During the conference activities, Dr. Kelani participated in a panel discussion focused on developing the pharmaceutical industry in the Arab world and localizing the manufacturing of biological products. He also delivered a lecture on the success of the Egyptian experience in localizing the Biologics and Biosimilars industry, highlighting how the dream of establishing the EIPICO 3 has turned into a reality. The facility has already commenced production of its first biological products, making it the first plant in Egypt and the Middle East to fully manufacture these biological preparations, spanning the entire process from the genetically modified cell line to the final product.

On the sidelines of the conference, Dr. Kelani met with numerous leaders of the Arab pharmaceutical industry, as well as pharmacy professors from several Arab universities, to discuss avenues for joint cooperation.
 Additionally, he met with a number of EIPICO’s agents from Jordan and Iraq.

In recognition of his fruitful efforts and extensive contributions to developing the pharmaceutical industry in Egypt and the Arab world, the leadership of the Arab Union of Manufacturers of Pharmaceuticals and Medical Appliances honored Dr. Ahmed Kelani during the event.












WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 2284486